Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses

Int J Mol Sci. 2022 Nov 11;23(22):13891. doi: 10.3390/ijms232213891.

Abstract

Herpesviruses are one of the most contagious DNA viruses that threaten human health, causing severe diseases, including, but not limited to, certain types of cancer and neurological complications. The overuse and misuse of anti-herpesvirus drugs are key factors leading to drug resistance. Therefore, targeting human herpesviruses with natural products is an attractive form of therapy, as it might improve treatment efficacy in therapy-resistant herpesviruses. Plant polyphenols are major players in the health arena as they possess diverse bioactivities. Hence, in this article, we comprehensively summarize the recent advances that have been attained in employing plant non-flavonoid polyphenols, such as phenolic acids, tannins and their derivatives, stilbenes and their derivatives, lignans, neolignans, xanthones, anthraquinones and their derivatives, curcuminoids, coumarins, furanocoumarins, and other polyphenols (phloroglucinol) as promising anti-herpesvirus drugs against various types of herpesvirus such as alpha-herpesviruses (herpes simplex virus type 1 and 2 and varicella-zoster virus), beta-herpesviruses (human cytomegalovirus), and gamma-herpesviruses (Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus). The molecular mechanisms of non-flavonoid polyphenols against the reviewed herpesviruses are also documented.

Keywords: Epstein–Barr virus (EBV); HSV-1; HSV-2; Kaposi sarcoma-associated herpesvirus (KSHV); antiviral activity; herpes simplex virus; human cytomegalovirus (HCMV); natural products; non-flavonoid polyphenols; polyphenols; varicella-zoster virus (VZV).

Publication types

  • Review

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Epstein-Barr Virus Infections* / drug therapy
  • Herpesviridae Infections* / drug therapy
  • Herpesvirus 3, Human
  • Herpesvirus 4, Human
  • Humans
  • Polyphenols / pharmacology
  • Polyphenols / therapeutic use

Substances

  • Antiviral Agents
  • Polyphenols

Grants and funding

This research received no external funding.